VistaGen Therapeutics, Inc.VTGNNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P44
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -35.03% |
| Q3 2025 | 4.38% |
| Q2 2025 | -22.43% |
| Q1 2025 | -13.23% |
| Q4 2024 | -12.97% |
| Q3 2024 | -11.37% |
| Q2 2024 | -19.01% |
| Q1 2024 | -49.59% |
| Q4 2023 | 136.31% |
| Q3 2023 | 282.31% |
| Q2 2023 | -44.94% |
| Q1 2023 | -43.77% |
| Q4 2022 | -30.17% |
| Q3 2022 | -35.78% |
| Q2 2022 | -28.91% |
| Q1 2022 | -20.67% |
| Q4 2021 | -5.31% |
| Q3 2021 | -7.40% |
| Q2 2021 | -28.99% |
| Q1 2021 | -48.38% |
| Q4 2020 | 731.99% |
| Q3 2020 | 235.20% |
| Q2 2020 | 10.17% |
| Q1 2020 | 13.81% |
| Q4 2019 | -65.79% |
| Q3 2019 | -323.30% |
| Q2 2019 | -81.13% |
| Q1 2019 | 266.62% |
| Q4 2018 | -64.31% |
| Q3 2018 | 10.26% |
| Q2 2018 | -53.97% |
| Q1 2018 | -58.78% |
| Q4 2017 | 537.06% |
| Q3 2017 | -151.59% |
| Q2 2017 | -193.61% |
| Q1 2017 | -76.77% |
| Q4 2016 | -39.24% |
| Q3 2016 | -57.96% |
| Q2 2016 | 186.13% |
| Q1 2016 | -55.04% |